Moyamoya Disease and the Risk of Parkinson's Disease
Dallah Yoo(Kyung Hee University), Tae‐Beom Ahn(Seoul National University Hospital), In‐Hwan Oh(University of Ulsan), Jae‐Kyung Won(Seoul National University Hospital), Jeong‐Yong Shin(Sungkyunkwan University), Ye‐Rin Lee(Kyung Hee University), Ji Hun Kim(Pohang University of Science and Technology), Yunjong Lee(Sungkyunkwan University), Jiwon Cheon(Sungkyunkwan University)
Cited by 0
Related Papers
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
|Proceedings of the National Academy of Sciences|2010|282
Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
|Proceedings of the National Academy of Sciences|2011|263
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
|Proceedings of the National Academy of Sciences|2015|259